MTHFR Gene Variant: What It Means for Your Health and How Nutrition Can Help

The MTHFR gene variant is one of the most discussed findings in functional medicine, and also one of the most misunderstood. If you have been told you carry an MTHFR variant, it is worth understanding what it actually means for your health, what it does not mean, and what you can do about it through nutrition.

What Is MTHFR?

MTHFR stands for methylenetetrahydrofolate reductase, an enzyme responsible for converting folate into its active form, 5-methyltetrahydrofolate (5-MTHF). This active form of folate is required for a critical biochemical process called methylation.

Methylation happens billions of times per second in every cell in your body. It is involved in DNA repair, gene expression, neurotransmitter production and breakdown, detoxification, immune regulation, and hormonal metabolism.

MTHFR variants (the two most clinically relevant are C677T and A1298C) reduce the efficiency of this enzyme. Depending on whether you carry one or two copies of the variant, MTHFR activity can be reduced by 30 to 70 percent [1].

How Common Is It?

MTHFR variants are extremely common. Approximately 40 to 60 percent of the general population carries at least one copy of a clinically relevant MTHFR variant [2]. Having the variant does not mean you will inevitably develop health problems. But it does mean that your methylation capacity may be reduced, and that nutritional support can meaningfully improve function.

Health Implications of MTHFR Variants

Elevated Homocysteine

The most clinically important downstream consequence of reduced MTHFR activity is elevated homocysteine. Homocysteine is an amino acid produced during methionine metabolism. Normally, adequate methylfolate recycles homocysteine back into methionine. When methylation is impaired, homocysteine accumulates.

Elevated homocysteine is a well-established risk factor for cardiovascular disease, stroke, and adverse pregnancy outcomes [3]. It is also associated with cognitive decline, depression, and recurrent miscarriage.

Mood and Mental Health

Methylation is required for the synthesis of neurotransmitters including serotonin, dopamine, and noradrenaline. Impaired methylation from MTHFR variants is associated with increased rates of depression, anxiety, and PMDD [4].

This connects directly to nervous system regulation: when methylation is impaired, the neurotransmitters that support mood and stress resilience are harder to produce and maintain.

Hormonal Metabolism

Methylation is involved in oestrogen metabolism through the liver. Impaired methylation can contribute to oestrogen dominance by reducing the body's ability to convert and clear oestrogen metabolites efficiently. This is a significant factor in oestrogen-sensitive conditions including PMDD, endometriosis, and hormonally-driven histamine intolerance.

Detoxification

Phase II liver detoxification relies on methylation. Reduced MTHFR function may impair the body's ability to process and excrete environmental toxins, medications, and hormonal metabolites. This is where MTHFR often intersects with the COMT variant, which affects catecholamine and oestrogen clearance through a separate but related methylation pathway.

Nutritional Support for MTHFR

Active Folate, Not Folic Acid

The most important nutritional intervention for MTHFR is replacing synthetic folic acid with active methylfolate (5-MTHF). People with MTHFR variants cannot efficiently convert folic acid into its active form. Supplementing with 5-MTHF bypasses the impaired enzyme step entirely [5].

This is particularly important in pregnancy, where folate requirements are high and MTHFR-related folate insufficiency is a significant risk factor for neural tube defects. Women planning pregnancy should ensure their prenatal supplement contains methylfolate, not folic acid.

Active B12 (Methylcobalamin)

Vitamin B12 works alongside folate in the methylation cycle. Methylcobalamin (the active form) is preferred over cyanocobalamin for individuals with MTHFR variants, as it is immediately bioavailable without requiring conversion steps that may be impaired.

Vitamin B6 (P5P)

Pyridoxal-5-phosphate (P5P), the active form of B6, is a cofactor for the transsulfuration pathway that converts homocysteine to cysteine. B6 is therefore important for keeping homocysteine levels in check and for supporting serotonin synthesis.

Riboflavin (B2)

Riboflavin is the cofactor for the MTHFR enzyme itself. Some research suggests that riboflavin supplementation can partially compensate for reduced MTHFR enzyme activity, particularly in the C677T TT homozygous genotype [6].

Magnesium and Zinc

Both magnesium and zinc support multiple steps in the methylation cycle. Deficiencies in these minerals are common and further impair already-reduced MTHFR function.

Reduce Methyl Blocking Nutrients

High doses of synthetic folic acid can actually block methylfolate receptors and worsen methylation in people with MTHFR variants. Checking all supplements, fortified foods, and medications for synthetic folic acid content is an important step.

Testing

MTHFR status can be identified through genetic testing (often included in standard nutrigenomic panels). More importantly, functional markers including homocysteine, active B12, methylfolate, and red cell folate should be assessed to understand how significantly your methylation pathway is impaired in practice.

A full picture of methylation status, hormonal metabolism, and nutrient levels is best obtained through comprehensive functional testing with a registered clinical nutritionist.

Found out you have an MTHFR variant and not sure what to do?

Book a Clinical Case Assessment with Kirstie to understand what your result means for your health and what nutritional support would look like for you.

Book Your Free Discovery Call

References

• Frosst P, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics. 1995;10(1):111-113. PubMed

• Wilcken B, et al. Geographical and ethnic variation of the 677C-->T allele of 5,10 methylenetetrahydrofolate reductase. American Journal of Human Genetics. 2003;72(6):1377-1383. PubMed

• Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA. 2002;288(16):2015-2022. PubMed

• Gilbody S, et al. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders. Human Psychopharmacology. 2007;22(1):7-14. PubMed

• Lamers Y. Folate recommendations for pregnancy, lactation, and infancy. Annals of Nutrition and Metabolism. 2011;59(1):32-37. PubMed

• McNulty H, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C->T polymorphism. Circulation. 2006;113(1):74-80. PubMed